Announced Fri, 2 Oct, 2026 · 08:58 IST
Mexican patent granted for antiviral compounds
GODAVARIB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+0.4%1-day move
₹227.95
prior close
₹229.30
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.2+1.2+0.7+0.3+0.4-0.7-3.5———————
Up moveDown movePending
AI summary
The Mexican Patent Office (IMPI) has granted Godavari Biorefineries a patent (No. 438818) titled Use of Compounds for Treating Viral Infections. The patent covers compounds that inhibit V-ATPase activity in cells, with applications in manufacturing medicaments for treating viral infections. Filed May 10, 2021, the patent is valid for 20 years, expiring May 10, 2041. Certificate issued September 15, 2026.
Likely market impact
Strengthens IP portfolio for antiviral treatments in Mexico; potential licensing or partnership opportunities. No immediate revenue effect.